EP3471805A1 — Drug delivery device with electronics
Assigned to Norton Waterford Ltd · Expires 2019-04-24 · 7y expired
What this patent protects
A device (100) for delivering medication to a user may include a main body (104), an electronics module (102), and a slider. The main body may include a mouthpiece (106), a medication reservoir, and a mouthpiece cover (108), where the mouthpiece cover may be hinged to the main bo…
USPTO Abstract
A device (100) for delivering medication to a user may include a main body (104), an electronics module (102), and a slider. The main body may include a mouthpiece (106), a medication reservoir, and a mouthpiece cover (108), where the mouthpiece cover may be hinged to the main body. The electronics module may include a communication circuit, a pressure sensor, and a switch. The slider may be configured to engage the switch when the mouthpiece cover moves from a closed position to an open position. The switch may be configured to switch the electronics module from an off state or a sleep state to an active state. The electronics module may be configured to never return to the off state after the mouthpiece cover is moved to expose the mouthpiece for the first time by the user.
Drugs covered by this patent
- Cutivate (FLUTICASONE PROPIONATE) · Teva Pharm
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.